Literature DB >> 16381172

[The proinflammatory activity of lipopolysaccharide].

Joanna Saluk-Juszczak1, Barbara Wachowicz.   

Abstract

Lipopolysaccharide (LPS) is the major component of the outer membranes of the walls of gramnegative bacteria that protects bacterial cells against antibacterial agents. LPS is the heteropolimer consisting of two parts: the hydrophobic lipid A and hydrophilic polisaccharide. After lysis of bacterial cells LPS is released into the circulation and it is able to activate the immunological system by stimulation of monocytes, macrophages, neutrophils, blood platelets and endothelial cells. LPS can bind to plasma proteins and form complexes that increase toxic activity of LPS and affinity of LPS to cell receptors. The activation of immune cells by LPS leads to release of inflammatory mediators: cytokines, chemokines, enzymes, eicosanoids, adhesion agents and free radicals that are responsible for progression of inflammatory reactions and may induce pathophysiological processes including septic shock.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16381172

Source DB:  PubMed          Journal:  Postepy Biochem        ISSN: 0032-5422


  15 in total

1.  Empathy in stroke rats is modulated by social settings.

Authors:  Kazutaka Shinozuka; Naoki Tajiri; Hiroto Ishikawa; Julian P Tuazon; Jea-Young Lee; Paul R Sanberg; Sydney Zarriello; Sydney Corey; Yuji Kaneko; Cesario V Borlongan
Journal:  J Cereb Blood Flow Metab       Date:  2019-08-01       Impact factor: 6.200

2.  Protocatechuic acid attenuates lipolysaccharide-induced acute lung injury.

Authors:  Miaomiao Wei; Xiao Chu; Lanxiang Jiang; Xiaofeng Yang; Qinren Cai; Chaochao Zheng; Xinxin Ci; Mingfeng Guan; Juxiang Liu; Xuming Deng
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

3.  Lipopolysaccharide-induced miR-1224 negatively regulates tumour necrosis factor-α gene expression by modulating Sp1.

Authors:  Yuna Niu; Delin Mo; Limei Qin; Chong Wang; Anning Li; Xiao Zhao; Xiaoying Wang; Shuqi Xiao; Qiwei Wang; Ying Xie; Zuyong He; Peiqing Cong; Yaosheng Chen
Journal:  Immunology       Date:  2011-02-14       Impact factor: 7.397

4.  Acute endotoxin-induced thymic atrophy is characterized by intrathymic inflammatory and wound healing responses.

Authors:  Matthew J Billard; Amanda L Gruver; Gregory D Sempowski
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

5.  Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver.

Authors:  Vasanthi R Sunil; Kinal J Patel; Marit Nilsen-Hamilton; Diane E Heck; Jeffrey D Laskin; Debra L Laskin
Journal:  Exp Mol Pathol       Date:  2007-03-30       Impact factor: 3.362

6.  G-protein signaling modulator-3, a gene linked to autoimmune diseases, regulates monocyte function and its deficiency protects from inflammatory arthritis.

Authors:  Patrick M Giguère; Matthew J Billard; Geneviève Laroche; Brian K Buckley; Roman G Timoshchenko; Marcus W McGinnis; Denise Esserman; Oded Foreman; Peng Liu; David P Siderovski; Teresa K Tarrant
Journal:  Mol Immunol       Date:  2012-12-29       Impact factor: 4.407

Review 7.  Cytokines, leptin, and stress-induced thymic atrophy.

Authors:  Amanda L Gruver; Gregory D Sempowski
Journal:  J Leukoc Biol       Date:  2008-05-21       Impact factor: 4.962

8.  Effects of cyanobacterial lipopolysaccharides from microcystis on glutathione-based detoxification pathways in the zebrafish (Danio rerio) embryo.

Authors:  Asha Jaja-Chimedza; Miroslav Gantar; Gregory D Mayer; Patrick D L Gibbs; John P Berry
Journal:  Toxins (Basel)       Date:  2012-05-25       Impact factor: 4.546

Review 9.  Pattern recognition receptor-dependent mechanisms of acute lung injury.

Authors:  Meng Xiang; Jie Fan
Journal:  Mol Med       Date:  2009-11-02       Impact factor: 6.354

10.  Rabdosia japonica var. glaucocalyx Flavonoids Fraction Attenuates Lipopolysaccharide-Induced Acute Lung Injury in Mice.

Authors:  Chun-Jun Chu; Nai-Yu Xu; Xian-Lun Li; Long Xia; Jian Zhang; Zhi-Tao Liang; Zhong-Zhen Zhao; Dao-Feng Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-11       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.